Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

News

A2 Milk gets China registration approval

Simone Ziaziaris  |  28 Sep 2017Text size  Decrease  Increase  |  
Email to Friend

Page 1 of 1

SYDNEY - [AAP] The A2 Milk Company (ASX: A2M) has had its application to continue selling its infant formula products in China approved by the Asian nation's regulatory body.

The mandatory application to the China Food and Drug Administration (CFDA) was submitted in May by formula manufacturer Synlait Milk (ASX: SM1), which has been in partnership with A2 Milk since 2010.

All manufacturers of infant formula must register brands and recipes with the CFDA in order to import products into China from January 1.

Synlait chief executive John Penno described the registration, which included product testing certification of manufacturing standards, formulation assessment and packaging changes, as another milestone in its long-term partnership with A2 Milk.

"Having successfully navigated the process, in conjunction with The A2 Milk Company, we are now in a stronger position for future applications of other Synlait customers," Mr Penno said.

Synlait and A2 Milk joined forces in 2010 to manufacture infant formula made from milk containing only the A2 beta-casein protein type and free from the A1 protein type.

In March, A2 Milk bought 8.2 per cent of Synlait, to "further strengthen the relationship between the two organisations".

 

AAP logo image

© [2017] Australian Associated Press Pty Limited (AAP) or its Licensors. This is the Morningstar service with content provided by AAP where indicated. AAP reserves all rights, including copyright, in services provided by it. The information in the service is for personal use only, does not constitute financial product advice (whether general or personal) and may not be re-written, copied, re-sold or re-distributed, framed, linked or otherwise used whether for compensation of any kind or not, without the prior written permission of AAP. You should seek advice from a professional financial adviser before making decision to acquire or dispose of a financial product.

This service is published for general information purposes only without assuming a duty of care. AAP is not in the business of providing financial product advice (whether personal or general advice), and gives no warranty, guarantee or other representation about the accuracy of the information or images contained in this service. AAP is not liable for errors, omissions in, delays or interruptions to or cessation of the services through negligence or otherwise. The globe symbol and "AAP" are registered trademarks.

Email To Friend